 | for the Xopenex Pediatric Asthma Group |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
for the Xopenex Pediatric Asthma:Expert Impact
Concepts for whichfor the Xopenex Pediatric Asthmahas direct influence:Racemic albuterol,Metered dose,Dose inhaler,90 microg,Levalbuterol racemic,Albuterol asthma,Safety levalbuterol,Bronchodilator agents.
for the Xopenex Pediatric Asthma:KOL impact
Concepts related to the work of other authors for whichfor which for the Xopenex Pediatric Asthma has influence:Racemic albuterol,Inhaled corticosteroids,Acute asthma,Rac lev,Anticholinergics children,Treatment recommendations,Patients exacerbation.
KOL Resume for for the Xopenex Pediatric Asthma Group
| Year |
|---|
| Concept | World rank |
|---|---|
| safety levalbuterol | #16 |
| inhalers spirometry | #19 |
| study levalbuterol | #21 |
| levalbuterol racemic | #65 |
| levalbuterol | #82 |
| Sign-in to see all concepts, it's free! | |
Prominent publications by for the Xopenex Pediatric Asthma Group
OBJECTIVE: To evaluate the efficacy and safety of levalbuterol metered dose inhaler (MDI) in children aged 4-11 years (n = 173).
RESEARCH DESIGN AND METHODS: Multicenter, randomized, double-blind 28-day study of QID levalbuterol 90 microg, racemic albuterol 180 mug, and placebo (2:1:1 ratio). Serial spirometry was performed on Days 0, 14, and 28. The primary endpoint was the double-blind average peak percent (%) change in FEV(1) from visit pre-dose; the primary comparison was with ...
| Known for Racemic Albuterol | Metered Dose | Patients Asthma | 90 Microg | Administration Inhalation |
